Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities research analysts at William Blair lifted their Q2 2024 earnings per share estimates for shares of Biogen in a research report issued on Thursday, April 25th. William Blair analyst M. Minter now anticipates that the biotechnology company will post earnings per share of $3.79 for the quarter, […]